It has been reported that elevated COX-2 levels predicted poorer survival of non-small cell lung cancer (14), and higher COX-2 expression was significantly associated with histological type, lymph node metastasis, and venous invasion of liver cancer (15). The gene discussed is PTGS2; the disease is non-small cell lung carcinoma.